Quality Continuous Improvement (CI) Partner, Greater Asia (GA)

Advanced individual contributor responsible for hands-on delivery of Quality training, capability building, coaching, Continuous Improvement and Quality Excellence across the global Quality organization. Reports to the Associate Director, BD Excellence Quality and GPO NC, RCA & PD. Translates enterprise training direction into instructor-led, virtual and blended learning solutions; coaches associates, leaders and subject matter experts; and verifies effective application of learning in the workplace.

The position operates in a highly regulated life-sciences environment and requires expertise in Quality systems, compliant documentation, investigations, RCA, problem solving, continuous improvement and inspection readiness. Familiarity with FDA and ICH regulatory expectations is required. The role supports medical-device, pharmaceutical, biologics or similar regulated environments.

Bachelor's degree in Life Sciences, Sciences, Engineering, Quality, Education or related discipline required. MBA or equivalent business experience preferred. Requires 5+ years of experience in a regulated life-science, medical-device, pharmaceutical, biologics or similar environment. Demonstrated Quality/technical training experience in instructor-led, virtual and blended formats is required. Audit/inspection preparation, remediation, training-effectiveness and coaching experience are preferred.

The CI Partner influences without direct authority by building credibility through subject-matter expertise, facilitation, coaching and execution. The role works within a matrix organization, collaborates across functions, supports senior leadership and drives alignment and measurable business impact. BD leadership expectations include delivering meaningful results, collaborating globally, removing obstacles, empowering others, leveraging the matrix, embracing innovation and continuously improving established approaches.

The role is Greater Asia region based and requires approximately 25-50% domestic and international travel.